How Race and Class Impact Schizophrenia and Substance-Use Diagnoses

4
A new article explores how psychiatric diagnoses are differentially applied to people of different racial and class backgrounds.

Researchers Find that Textbooks Include Biased Information About ADHD

5
A review of academic textbooks finds that they often leave out effect sizes and molecular genetics findings, both of which suggest minimal impact of genetics on ADHD. Instead, textbooks focus on overblown conclusions from behavioral studies.

Relaxation Techniques for Depression and Anxiety in the Elderly

3
-Time magazine looks at the effects of a number of relaxation techniques on depression and anxiety in elderly people.

Taking “Holidays” from ADHD Drugs Helps Prevent Growth Retardation in Children

10
It's common for children and adolescents to take prolonged "drug holidays" from their ADHD medications during summer months away from school, and there appear...

Bullying & its Long-Term Effects on Wellness

2
Psychologist William Copeland writes for Mental Health Recovery that “bullying can occur at any age and the effects of which remain harmful long after the behavior has been endured.” “We, as a society, are just beginning to understand and come to terms with the havoc that bullying wreaks on the emotional lives of its victims.

Depression Discrimination More Severe in High Income Countries

7
According to a study published in this month’s British Journal of Psychiatry, people diagnosed with depression in high-income countries are more likely to limit...

“Sales of ADHD Meds Are Skyrocketing. Here’s Why.”

4
-Mother Jones looks at drug company promotional efforts, expanded diagnostic criteria, and the appeal of amphetamines to high-performance cultures globally.

The Autism Paradox

1
In this piece for Aeon, Bonnie Evans chronicles the history of the diagnosis of autism, from its establishment as a marker of dysfunction and impairment to the...

Fact-Checking the General Counsel in the Markingson Case

1
Ever since critics began asking questions about the death of Dan Markinson in a clinical trial at the University of Minnesota, the General Counsel for the university, Mark Rotenberg, has responded with a uniform message: the case has already been investigated many times, and no wrongdoing has ever been found. That's how Rotenberg responded to my article about the case in Mother Jones, and that's how he responded last week to the news that the Board of Social Work had issued a “corrective action” to the study coordinator for the clinical trial in which Markingson died.

More Evidence for the Lasting Psychological Impact of Lead Exposure in Childhood

3
New research points to numerous harmful effects of high-level lead exposure in childhood on adult mental health and personality characteristics.

Rise in Children With Mental Health Concerns After Terror Attacks

4
From The Guardian: According to the Royal College of Psychiatrists, the number of children and young people seeking mental health support has spiked since recent...

Is School Driving Kids Literally Crazy?

2
From FEE: School may have a negative impact on children's and teens' mental health: children's psychiatric emergency room visits drop precipitously over the summer and increase...

Parachute NYC Peer Support Program Presents Challenges and Opportunities

2
Anthropologists study Parachute NYC to identify challenges and opportunities for implementing peer support and Open Dialogue practices.

Your Instagram Posts May Hold Clues to Your Mental Health

1
From The New York Times: New research suggests that Instagram users who have been diagnosed with depression tend to post darker, bluer, and grayer photos...

A Review of Issues Surrounding Marijuana and Madness

5
-What does the balance of evidence say about the relationship between cannabis use and increased risk of psychotic reactions?

20-Year Data Show Antipsychotics Do Not Reduce Psychosis

13
Martin Harrow's study tracing the effects of antipsychotics on 139 schizophrenia (SZ) and mood-disordered patients over 20 years, just published in Psychological Medicine, finds...

1 Boring Old Man Bores Even More Into Study 329’s Raw Data

0
1 Boring Old Man bores ever more deeply into the newly available raw data from GlaxoSmithKline's study of Paxil in children, finding that "if...

Researchers Test Harms and Benefits of Long Term Antipsychotic Use

28
Researchers from the City College of New York and Columbia University published a study this month testing the hypothesis that people diagnosed with schizophrenia treated long-term with antipsychotic drugs have worse outcomes than patients with no exposure to these drugs. They concluded that there is not a sufficient evidence base for the standard practice of long-term use of antipsychotic medications.

Neuroleptics for Children: Harvard’s Shame

28
Thirty years ago, the prescription of neuroleptic drugs to children under 14 years of age was almost unheard of. It was rare in adolescents, and even in adults was largely confined to individuals who had been given the label schizophrenic or bipolar. By 1993 about a quarter of 1% of the national childhood population were receiving antipsychotic prescriptions during office visits. The percentage for adolescents was about three quarters of 1%. By 2009, these figures had increased to 1.83% and 3.76% respectively. The devastating effects of these neurotoxic drugs are well known, and it is natural to wonder what forces might be driving this trend.

Go to Sleep

5
A blog in Scientific American reviews sleep’s role in "Obesity, Schizophrenia, Diabetes... Everything".  The article notes  a tight link between depression and sleep apnea,...

One in Five Australian Families Tranquilize their Kids for Long Journeys

3
-Nearly one in five families in New South Wales, Australia admitted that they give tranquilizing drugs to their children during long road trips.

“Are Doctors Diagnosing Too Many Kids With ADHD?”

1
Salon.com points out that "While data point to at least some over diagnosis (of ADHD), at least in boys, the extent of this problem...

SCOTUS Declines Risperdal Appeal, J&J to Pay $124 M

10
On Monday, the US Supreme Court declined to hear Johnson and Johnson’s final appeal, forcing the company to pay $124 million for the deceptive marketing of the antipsychotic Risperdal. In 2011, South Carolina ordered the company to pay $327 million for pursuing “profits-at-all-costs” in its efforts to persuade doctors to prescribe their drug, but the fine was lowered to $136 million last year. The company had hoped to argue that the remaining penalties constituted an “excessive fine” and was supported by PhRMA, the Washington Legal Foundation, the Cato Institute and the Chamber of Commerce.

Psychologist Who Set Standard for Diagnosing ADHD Dies at 84

4
From The New York Times: Keith Conners, the psychologist whose work established the first standards for diagnosing and treating what is now known as attention...

“Breaking the Silence: How I Conquered Selective Mutism”

0
-Danica Cotov discusses her many and varied efforts to deal with selective mutism throughout her childhood and teen years.